Alternative strategies might also include pH-responsive binders to only allow binding of the mAb to IL-6R within the acidified tumour microenvironment, or alternatively masking this binding unit with an anti-idiotypic binder connected via a cleavable linker. The gene discussed is IL6R; the disease is neoplasm.